CRIS Current Research Information System

RIZZELLO, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 815
NA - Nord America 802
AS - Asia 361
AF - Africa 41
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.039
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 793
IT - Italia 310
SG - Singapore 137
CN - Cina 128
DE - Germania 95
GB - Regno Unito 89
SE - Svezia 72
NL - Olanda 68
IN - India 42
IE - Irlanda 38
RU - Federazione Russa 28
AT - Austria 20
CI - Costa d'Avorio 20
FI - Finlandia 16
FR - Francia 16
BG - Bulgaria 15
BR - Brasile 13
TG - Togo 13
HK - Hong Kong 12
ES - Italia 10
KR - Corea 9
ID - Indonesia 8
JO - Giordania 8
UA - Ucraina 8
CA - Canada 7
PH - Filippine 7
CH - Svizzera 6
EE - Estonia 6
BE - Belgio 5
ZA - Sudafrica 5
CZ - Repubblica Ceca 4
NG - Nigeria 3
TR - Turchia 3
MX - Messico 2
PE - Perù 2
PL - Polonia 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BD - Bangladesh 1
CL - Cile 1
CY - Cipro 1
EC - Ecuador 1
GR - Grecia 1
JP - Giappone 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 2.039
Salva come PNG Salva come JPEG
Città #
Chandler 122
Singapore 113
Bologna 110
Ashburn 73
Southend 73
Fairfield 63
Dublin 38
Santa Clara 38
Woodbridge 31
Wilmington 27
Seattle 25
Boardman 24
Houston 24
Princeton 24
Hyderabad 22
Cambridge 21
Abidjan 20
Milan 18
Ann Arbor 16
New York 16
Sofia 15
Fabriano 14
Turin 14
Vienna 14
Bremen 13
Helsinki 13
Lomé 13
Redmond 13
Beijing 12
Hong Kong 12
Amsterdam 11
Los Angeles 9
Nanjing 9
Seoul 9
Amman 8
Falkenstein 8
Jakarta 8
Nuremberg 8
Berlin 7
Florence 7
Frankfurt am Main 7
Bern 6
Dearborn 6
Munich 6
Nanchang 6
Padova 6
Westminster 6
Redwood City 5
Riola 5
San Diego 5
Shanghai 5
Toronto 5
Yubileyny 5
Anoia Superiore 4
Bari 4
Brussels 4
Changsha 4
Falls Church 4
Paris 4
Rome 4
San Giovanni in Persiceto 4
Shenyang 4
York 4
Zhengzhou 4
Abeokuta 3
Boydton 3
Cagliari 3
Des Moines 3
Fuzhou 3
Guangzhou 3
Javea 3
Lappeenranta 3
Pianoro 3
Saint Petersburg 3
Springfield 3
Stilo 3
São Paulo 3
Verona 3
Wuhan 3
Ankara 2
Belgrade 2
Bodio Lomnago 2
Brno 2
Brookline 2
Chongqing 2
Donostia / San Sebastian 2
Hockenheim 2
Kiel 2
Kiev 2
Kilburn 2
Leawood 2
Livorno 2
Manchester 2
Medford 2
Mexico City 2
Naples 2
Palma 2
Parma 2
Pavia 2
Pisa 2
Totale 1.319
Salva come PNG Salva come JPEG
Nome #
Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma 145
A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma 143
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens 139
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma 131
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma 129
Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents 126
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma 122
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia 119
Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma 117
null 98
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients 98
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients 80
Emerging and current treatment combinations for transplant-ineligible multiple myeloma patients 80
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases 68
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients 62
Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma 57
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma 51
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study 45
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 43
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features 41
Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review 41
Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight 37
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study 34
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients 31
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis 27
Abstract 2700: Negative selective pressure exerted by maintenance therapy promotes the extinction of sub-clones carrying high-risk lesions in multiple myeloma 21
Interference of daratumumab and efficacy of plerixafor on haematopoietic stem cell collection in Multiple Myeloma 19
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma 16
Clinical Presentation and Long‐Term Survival Outcomes of Patients With Monoclonal Gammopathy of Renal Significance (MGRS): A Multicenter Retrospective Study 13
Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma 7
Totale 2.140
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.966
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 0 0 0 0 0 18 4
2020/2021103 21 4 6 3 2 7 2 13 15 6 10 14
2021/2022301 7 13 15 37 14 12 12 25 16 46 56 48
2022/2023498 40 53 19 81 43 41 17 19 83 18 48 36
2023/2024263 17 29 15 19 18 53 9 55 6 17 17 8
2024/2025716 68 68 94 98 74 31 72 33 37 114 27 0
Totale 2.140